Evidence map›Paper›PMID 39071149›Full record

ArticleFrontiers in public health2024

Clinical and treatment profiles of arterial hypertension in Mexico during the COVID-19 pandemic: a cross-sectional survey endorsed by the "Collaborative Group on Arterial Hypertension".

Silvia Palomo-Piñón, Neftali Eduardo Antonio-Villa, Ricardo Alfonso Rangel-Zertuche, María Guadalupe Berumen-Lechuga, Julio Manuel Medina-Serrano, Luis Rey García-Cortés, Oliva Mejia-Rodríguez, María de la Luz León-Vázquez, Roxana Del Socorro González-Dzib, Vidal José González-Coronado and 4 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Silvia Palomo-Piñón *Unidad de Investigación Médica en Enfermedades Nefrológicas Siglo XXI (UIMENSXII), Unidad Médica de Alta Especialidad Hospital de Especialidades "Dr. Bernardo Sepúlveda G" Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Neftali Eduardo Antonio-Villa *Departamento de Endocrinología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Ricardo Alfonso Rangel-ZertucheJefatura Prestaciones Médicas, Órgano de Operación Administrativa Desconcentrada, Instituto Mexicano del Seguro Social, Coahuila, Mexico.
María Guadalupe Berumen-LechugaJefatura de Servicios de Prestaciones Médicas, Órgano de Operación Administrativa Desconcentrada México Poniente, Toluca, Mexico.
Julio Manuel Medina-SerranoCoordinación de Planeación y Enlace Institucional, Órgano de Operación Administrativa Desconcentrada en Sinaloa, Instituto Mexicano del Seguro Social, Culiacán, Sinaloa, Mexico.
Luis Rey García-CortésCoordinación de Planeación y Enlace Institucional, Jefatura de Servicios de Prestaciones Médicas, Órgano de Operación Administrativa Desconcentrada Regional Estado de México Oriente, Instituto Mexicano del Seguro Social, Oriente, Mexico City, Mexico.
Oliva Mejia-RodríguezCentro de Investigación Biomédica de Michoacán del Instituto Mexicano del Seguro Social and by Escuela de Medicina, Campus Morelia, UVAQ, Michoacán, Mexico.
María de la Luz León-VázquezCoordinación de Planeación e Enlace Institucional, Órgano Operativo de Administración Desconcentrada en Tlaxcala, Instituto Mexicano del Seguro Social, Tlaxcala, Mexico.
Roxana Del Socorro González-DzibCoordinación de Investigación en Salud, Instituto Mexicano del Seguro Social en Campeche, Campeche, Mexico.
Vidal José González-CoronadoDepartamento de Cardiología Hospital Regional "1 Octubre", Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado, Mexico City, Mexico.
Cleto Álvarez-AguilarFacultad de Ciencias Médicas y Biológicas "Dr. Ignacio Chávez", Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacan, Mexico.
José Ramón Paniagua-SierraJefe de la Unidad de Investigación Médica en Enfermedades Nefrológicas Siglo XXI, Unidad Médica de Alta Especialidad Hospital de Especialidades "Dr. Bernardo Sepúlveda G" - Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Luis AlcocerInstituto Mexicano de Salud Cardiovascular, Mexico City, Mexico.
Collaborative Group on Arterial Hypertension from the Mexican Institute of Social Security

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Arterial hypertension is highly prevalent in Mexico; nevertheless, there are limited insights regarding its management during the COVID-19 pandemic. Here, we estimate the prevalence of clinical and treatment profiles of arterial hypertension and explore associated factors for undiagnosed and uncontrolled hypertension using a cross-sectional survey endorsed by the Collaborative Group on Arterial Hypertension from the Mexican Institute of Social Security. Methods: Our survey was conducted from May to November 2021 using the May-Measurement Month 2021 protocols of the International Society of Hypertension. Arterial hypertension (defined as: blood pressure [BP] ≥140/90 mmHg, previous diagnosis, or taking antihypertensives) and its clinical and treatment profiles were classified according to the World Hypertension League Expert Committee. Mixed-effects logistic regression models were used to explore associated factors for undiagnosed and uncontrolled hypertension. Results: Among 77,145 screened participants (women: 62.4%; median age: 46 [IQR: 32-59] years), the prevalence of arterial hypertension was 35.7% (95% CI: 35.3-36.0, Conclusion: Our findings suggest that adverse arterial hypertension profiles, mainly undiagnosed and uncontrolled hypertension, were highly prevalent during the context of the COVID-19 pandemic in Mexico.

Indexed as

Antihypertensive AgentsCOVID-19HypertensionAdultCross-Sectional StudiesFemaleHumansMaleMexicoMiddle AgedPandemicsPrevalenceSARS-CoV-2Surveys and QuestionnairesAntihypertensive Agentsblood pressureCOVID-19disease managementepidemiologyhypertensionpublic health

Identifiers

PMID39071149
PMCPMC11272620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.